These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
419 related items for PubMed ID: 29579353
1. Northern Italy in the American South: Assessing interobserver reliability within the Milan System for Reporting Salivary Gland Cytopathology. Hollyfield JM, O'Connor SM, Maygarden SJ, Greene KG, Scanga LR, Tang S, Dodd LG, Wobker SE. Cancer Cytopathol; 2018 Jun; 126(6):390-396. PubMed ID: 29579353 [Abstract] [Full Text] [Related]
2. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience. Viswanathan K, Sung S, Scognamiglio T, Yang GCH, Siddiqui MT, Rao RA. Cancer Cytopathol; 2018 Aug; 126(8):541-551. PubMed ID: 29797690 [Abstract] [Full Text] [Related]
4. Utility of the Milan System for Reporting Salivary Gland Cytology, with focus on the incidence and histologic correlates of atypia of undetermined significance (AUS) and salivary gland neoplasm of uncertain malignant potential (SUMP): A 3-year institutional experience. Cormier CM, Agarwal S. Cancer Cytopathol; 2022 Apr; 130(4):303-312. PubMed ID: 34875145 [Abstract] [Full Text] [Related]
5. Application of the Milan System for Reporting Salivary Gland Cytopathology to cystic salivary gland lesions. Maleki Z, Allison DB, Butcher M, Kawamoto S, Eisele DW, Pantanowitz L. Cancer Cytopathol; 2021 Mar; 129(3):214-225. PubMed ID: 33002347 [Abstract] [Full Text] [Related]
6. Application of the Milan System for Reporting Salivary Gland Cytopathology in pediatric patients: An international, multi-institutional study. Maleki Z, Saoud C, Viswanathan K, Kilic I, Tommola E, Griffin DT, Heider A, Petrone G, Jo VY, Centeno BA, Saieg M, Mikou P, Fadda G, Ali SZ, Kholová I, Wojcik EM, Barkan GA, Eisele DW, Bellevicine C, Vigliar E, Wiles AB, Al-Ibraheemi A, Allison DB, Dixon GR, Chandra A, Walsh JM, Baloch ZW, Faquin WC, Krane JF, Rossi ED, Pantanowitz L, Troncone G, Callegari FM, Klijanienko J. Cancer Cytopathol; 2022 May; 130(5):370-380. PubMed ID: 35081269 [Abstract] [Full Text] [Related]
7. Application of the Milan System for Reporting Salivary Gland Cytopathology: Experience of an academic institution in a tertiary academic medical center. Castrodad-Rodríguez CA, Lajara S, Khader SN, Colanta AB, Guerrero DR, El Hussein S, Hakima L. Cancer Cytopathol; 2021 Mar; 129(3):204-213. PubMed ID: 33030811 [Abstract] [Full Text] [Related]
8. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): An international effort toward improved patient care-when the roots might be inspired by Leonardo da Vinci. Rossi ED, Faquin WC. Cancer Cytopathol; 2018 Sep; 126(9):756-766. PubMed ID: 30264905 [Abstract] [Full Text] [Related]
9. Application of the Milan System for Reporting Salivary Gland Cytopathology: A retrospective study in a tertiary institute. Chen YA, Wu CY, Yang CS. Diagn Cytopathol; 2019 Nov; 47(11):1160-1167. PubMed ID: 31313521 [Abstract] [Full Text] [Related]
10. Application of the Milan System for Reporting Salivary Gland Cytopathology: A Retrospective 12-Year Bi-institutional Study. Wu HH, Alruwaii F, Zeng BR, Cramer HM, Lai CR, Hang JF. Am J Clin Pathol; 2019 May 03; 151(6):613-621. PubMed ID: 30852595 [Abstract] [Full Text] [Related]
11. Retrospective application of the Milan System for reporting salivary gland cytopathology: A Cancer Center experience. Leite AA, Vargas PA, Dos Santos Silva AR, Galvis MM, de Sá RS, Lopes Pinto CA, Kowalski LP, Saieg M. Diagn Cytopathol; 2020 Sep 03; 48(9):821-826. PubMed ID: 32374949 [Abstract] [Full Text] [Related]
12. Application of the Milan System for Reporting Pediatric Salivary Gland Cytopathology: Analysis of histologic follow-up, risk of malignancy, and diagnostic accuracy. Wang H, Weiss VL, Borinstein SC, Ely K, Johnson J, Coogan A, Belcher R, Mannion K, Virgin F, Liang J. Cancer Cytopathol; 2021 Jul 03; 129(7):555-565. PubMed ID: 33595882 [Abstract] [Full Text] [Related]
13. The Milan system for reporting salivary gland cytopathology: Single center experience with cell blocks. Behaeghe M, Vander Poorten V, Hermans R, Politis C, Weynand B, Hauben E. Diagn Cytopathol; 2020 Nov 03; 48(11):972-978. PubMed ID: 32506684 [Abstract] [Full Text] [Related]
14. The Milan system for reporting salivary gland cytology: A retrospective analysis of 1384 cases in a tertiary Southeast Asian institution. Lee JJL, Tan HM, Chua DYS, Chung JGK, Nga ME. Cancer Cytopathol; 2020 May 03; 128(5):348-358. PubMed ID: 32022995 [Abstract] [Full Text] [Related]
15. The utility of the Milan System as a risk stratification tool for salivary gland fine needle aspiration cytology specimens. Song SJ, Shafique K, Wong LQ, LiVolsi VA, Montone KT, Baloch Z. Cytopathology; 2019 Jan 03; 30(1):91-98. PubMed ID: 30303566 [Abstract] [Full Text] [Related]
16. A retrospective comparison of salivary gland fine needle aspiration reporting with the Milan system for reporting salivary gland cytology. Mullen D, Gibbons D. Cytopathology; 2020 May 03; 31(3):208-214. PubMed ID: 32061105 [Abstract] [Full Text] [Related]
17. Retrospective implementation of the Milan system for reporting salivary gland cytopathology; a review of 5 years in a specialized cancer center. Jaber OI, Shawash SI. Diagn Cytopathol; 2021 Feb 03; 49(2):187-194. PubMed ID: 33002325 [Abstract] [Full Text] [Related]
18. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study. Chowsilpa S, An D, Lose H, Huang X, Nayar R, Maleki Z. Cancer Cytopathol; 2019 Jun 03; 127(6):377-389. PubMed ID: 31116514 [Abstract] [Full Text] [Related]
19. Application of the Milan System for Reporting Salivary Gland Cytopathology: A Single Institutional Experience of 354 Cases with Cytologic-Histologic Correlation. Velez Torres JM, Tjendra Y, Zuo Y, Garcia-Buitrago M, Jorda M, Kerr DA, Gomez-Fernandez CR. Acta Cytol; 2022 Jun 03; 66(6):467-474. PubMed ID: 35738234 [Abstract] [Full Text] [Related]
20. Subtyping salivary gland neoplasm of uncertain malignant potential based on cell type demonstrates differential risk of malignancy. Hang JF, Alruwaii F, Zeng BR, Lai CR, Wu HH. Cancer Cytopathol; 2018 Nov 03; 126(11):924-933. PubMed ID: 30335220 [Abstract] [Full Text] [Related] Page: [Next] [New Search]